GSTP1 and pachyonychia congenita: It should be noted that GSTP1 rs1695 polymorphism, based on several meta-analyses, is likely to be associated with a risk of prostate cancer, [23,24] while the data on the association between GSTP1*Ala114Val rs1138272 polymorphism and PC risk are scarce.